| Symbol |
Name |
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
CADM1
|
cell adhesion molecule 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD68
|
CD68 molecule
|
|
CD7
|
CD7 molecule
|
|
CD99
|
CD99 molecule
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK2
|
checkpoint kinase 2
|
|
CMIP
|
c-Maf inducing protein
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane)
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
EBF1
|
early B-cell factor 1
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FAS
|
Fas cell surface death receptor
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GATA3
|
GATA binding protein 3
|
|
GLI3
|
GLI family zinc finger 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HOXB9
|
homeobox B9
|
|
HPSE
|
heparanase
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LTA
|
lymphotoxin alpha
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MIR135A1
|
microRNA 135a-1
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOTCH1
|
notch 1
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
PAX5
|
paired box 5
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SDC1
|
syndecan 1
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SYK
|
spleen tyrosine kinase
|
|
TBX21
|
T-box 21
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
